Cardinal Health CAH
NYSE CAH
$280.51 +2.37 (+0.85%)
As of: Nov 13, 2026 · 11:08 AM EST

Cardinal Health (CAH) Short-Term Debt issuances (2011 - 2012)

Updated

Cardinal Health (CAH) recorded Short-Term Debt issuances of $4.8 million in fiscal Q4 2012 (quarter ended Jun 30, 2012), up 6.7% from $4.5 million a year earlier and up 17.1% from the prior quarter.

Analysis

Cardinal Health (CAH) Short-Term Debt issuances (2011 - 2012) Analysis & Trends

For FY2012 (ended Jun 30, 2012), Cardinal Health reported Short-Term Debt issuances of $13 million, down 71.7% from FY2011.

  • Across earlier fiscal years, Short-Term Debt issuances came in at $46 million in FY2011.
  • Quarterly Short-Term Debt issuances has ranged from -$5 million in fiscal Q1 2012 to $41.5 million in fiscal Q3 2011 over the past five years.
  • Per Business Quant, the preceding three fiscal quarters came in at $4.1 million (Q3 2012), $9.1 million (Q2 2012) and -$5 million (Q1 2012).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Unitedhealth 361.41 Bn 242.04 Bn 35.71 Bn -
2 Mckesson 127.85 Bn 109.22 Bn 3.96 Bn -
3 Cvs Health 113.60 Bn 62.35 Bn 47.21 Bn -
4 Elevance Health 92.11 Bn -50.47 Bn 13.65 Bn -
5 Cigna 77.03 Bn 45.89 Bn 15.09 Bn -
6 Cencora 68.72 Bn 68.72 Bn 3.60 Bn -
7 Cardinal Health 65.08 Bn 48.24 Bn 2.60 Bn -
8 Humana 53.29 Bn -37.50 Bn 4.83 Bn -
9 Centene 33.93 Bn -40.20 Bn 8.24 Bn -
10 Molina Healthcare 10.55 Bn -24.45 Bn 1.36 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 4.80 Mn
Mar 31, 2012 4.10 Mn
Dec 31, 2011 9.10 Mn
Sep 30, 2011 -5.00 Mn
API Access

Cardinal Health Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=CAH&period=max&api_key=YOUR_API_KEY